Compare Cadila Healthcare with SHASUN PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs SHASUN PHARMA - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE SHASUN PHARMA CADILA HEALTHCARE/
SHASUN PHARMA
 
P/E (TTM) x 19.4 123.9 15.7% View Chart
P/BV x 2.6 8.5 30.5% View Chart
Dividend Yield % 1.3 0.2 568.9%  

Financials

 CADILA HEALTHCARE   SHASUN PHARMA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-19
SHASUN PHARMA
Mar-14
CADILA HEALTHCARE/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs43294 459.0%   
Low Rs30646 671.9%   
Sales per share (Unadj.) Rs128.6214.2 60.0%  
Earnings per share (Unadj.) Rs18.55.3 347.6%  
Cash flow per share (Unadj.) Rs24.415.8 154.2%  
Dividends per share (Unadj.) Rs3.501.00 350.0%  
Dividend yield (eoy) %0.91.4 66.2%  
Book value per share (Unadj.) Rs101.553.3 190.2%  
Shares outstanding (eoy) m1,023.7456.62 1,808.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.90.3 880.1%   
Avg P/E ratio x19.913.1 152.0%  
P/CF ratio (eoy) x15.14.4 342.7%  
Price / Book Value ratio x3.61.3 277.9%  
Dividend payout %18.918.7 100.7%   
Avg Mkt Cap Rs m378,1703,958 9,555.2%   
No. of employees `00012.4NA-   
Total wages/salary Rs m21,2412,164 981.8%   
Avg. sales/employee Rs Th10,585.0NM-  
Avg. wages/employee Rs Th1,707.8NM-  
Avg. net profit/employee Rs Th1,526.5NM-  
INCOME DATA
Net Sales Rs m131,65612,127 1,085.7%  
Other income Rs m2,011229 876.8%   
Total revenues Rs m133,66712,356 1,081.8%   
Gross profit Rs m29,7311,009 2,946.4%  
Depreciation Rs m5,986594 1,008.4%   
Interest Rs m1,935415 466.2%   
Profit before tax Rs m23,821230 10,370.5%   
Minority Interest Rs m4690-   
Prior Period Items Rs m00 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,303-73 -7,292.4%   
Profit after tax Rs m18,987302 6,284.6%  
Gross profit margin %22.68.3 271.4%  
Effective tax rate %22.3-31.7 -70.3%   
Net profit margin %14.42.5 578.9%  
BALANCE SHEET DATA
Current assets Rs m84,9816,884 1,234.4%   
Current liabilities Rs m73,4258,456 868.3%   
Net working cap to sales %8.8-13.0 -67.7%  
Current ratio x1.20.8 142.2%  
Inventory Days Days7562 120.9%  
Debtors Days Days110108 101.8%  
Net fixed assets Rs m133,4934,970 2,685.9%   
Share capital Rs m1,024113 903.8%   
"Free" reserves Rs m102,8392,875 3,577.1%   
Net worth Rs m103,8633,020 3,438.9%   
Long term debt Rs m39,4971,817 2,173.3%   
Total assets Rs m234,83113,347 1,759.4%  
Interest coverage x13.31.6 856.9%   
Debt to equity ratio x0.40.6 63.2%  
Sales to assets ratio x0.60.9 61.7%   
Return on assets %8.95.4 165.8%  
Return on equity %18.310.0 182.7%  
Return on capital %18.313.3 137.3%  
Exports to sales %046.4 0.0%   
Imports to sales %014.2 0.0%   
Exports (fob) Rs mNA5,622 0.0%   
Imports (cif) Rs mNA1,728 0.0%   
Fx inflow Rs m48,4045,843 828.5%   
Fx outflow Rs m11,5932,173 533.5%   
Net fx Rs m36,8113,669 1,003.2%   
CASH FLOW
From Operations Rs m28,823398 7,249.2%  
From Investments Rs m-57,387-1,635 3,509.9%  
From Financial Activity Rs m18,8461,309 1,440.2%  
Net Cashflow Rs m-7,10571 -9,978.9%  

Share Holding

Indian Promoters % 74.8 39.2 190.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 3.6 230.6%  
FIIs % 5.9 17.6 33.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 39.6 27.8%  
Shareholders   44,069 20,750 212.4%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   PIRAMAL ENTERPRISES  GSK PHARMA  DR. DATSONS LABS  DR. REDDYS LAB  NOVARTIS  

Compare CADILA HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Market Updates, IPO Buzz, and Top Cues in Focus Today(Pre-Open)

On Thursday, Indian share markets traded on a positive note throughout the day and ended higher.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 18.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (down 18.6% YoY). Sales on the other hand came in at Rs 30 bn (down 8.4% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

Use My Secret to Increase Your Trading Profits Today

Dec 10, 2019

What to do after every trade.

A Simple, 7-Step Checklist for Your Trading Success

Dec 4, 2019

What we can learn from one of the greatest traders to have ever lived.

Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020(Profit Hunter)

Dec 5, 2019

This corner of the market could provide more returns than blue chips in 2020.

Make the Most of the Smallcap Rebound with These Stocks(Profit Hunter)

Dec 3, 2019

Even amid a gloomy economic scenario, there are smallcaps that have grown earnings over last one and a half year and I believe these could be the strongest candidates for a smallcap rebound.

What Is the IPO Euphoria Signaling Us About the Markets?(The 5 Minute Wrapup)

Dec 2, 2019

2019 will be remembered as the year of great money-making IPOs...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Dec 12, 2019 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS